CHEBI:229213 - elacestrant

ChEBI IDCHEBI:229213
ChEBI Nameelacestrant
Stars
DefinitionA member of the class of tetralins that is 1,2,3,4-tetrahydronaphthalene which is substituted by hydroxy group at position 2 and by a 2-(ethyl{4-[2-(ethylamino)ethyl]benzyl}amino)-4-methoxyphenyl group at position 6R. It is a is an estrogen receptor degrader indicated for the treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
Last Modified16 April 2024
SubmitterAdnan
DownloadsMolfile
FormulaC30H38N2O2
Net Charge0
Average Mass458.646
Monoisotopic Mass458.29333
SMILES[H][C@@]1(c2ccc(OC)cc2N(CC)Cc2ccc(CCNCC)cc2)CCc2cc(O)ccc2C1
InChIInChI=1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1
InChIKeySIFNOOUKXBRGGB-AREMUKBSSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted base  A molecular entity capable of accepting a hydron from a donor (Brønsted acid).
Biological Role:
estrogen receptor antagonist  An antagonist at the estrogen receptor.
Applications:
anti-estrogen  A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
estrogen receptor antagonist  An antagonist at the estrogen receptor.
ChEBI Ontology
Outgoing Relation(s)
elacestrant (CHEBI:229213) has role anti-estrogen (CHEBI:50751)
elacestrant (CHEBI:229213) has role antineoplastic agent (CHEBI:35610)
elacestrant (CHEBI:229213) has role estrogen receptor antagonist (CHEBI:50792)
elacestrant (CHEBI:229213) is a monomethoxybenzene (CHEBI:25235)
elacestrant (CHEBI:229213) is a organic hydroxy compound (CHEBI:33822)
elacestrant (CHEBI:229213) is a secondary amino compound (CHEBI:50995)
elacestrant (CHEBI:229213) is a substituted aniline (CHEBI:48975)
elacestrant (CHEBI:229213) is a tertiary amino compound (CHEBI:50996)
elacestrant (CHEBI:229213) is a tetralins (CHEBI:36786)
IUPAC Name 
(6R)-6-[2-(ethyl{4-[2-(ethylamino)ethyl]benzyl}amino)-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol
INNs  Source
élacestrantWHO MedNet
elacestrantumWHO MedNet
elacestrantWHO MedNet
elacestrantWHO MedNet
Synonyms  Source
RAD-1901DrugBank
RAD1901DrugBank
ER-306323DrugBank
RAD 1901ChEBI
(R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-olChEBI
Brand Name  Source
OrserduDrugBank
Manual XrefsDatabases
DB06374DrugBank
D11671KEGG DRUG
ElacestrantWikipedia
I0VPDBeChem
Registry NumbersSources
CAS:722533-56-4KEGG DRUG
Citations